Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Tute Genomics Biomarker Discovery Platform to Support BYU Efforts

Published: Friday, July 25, 2014
Last Updated: Friday, July 25, 2014
Bookmark and Share
Brigham Young University to advance Alzheimer’s disease genetics research.

Tute Genomics has announced that its genome annotation and discovery platform will support Brigham Young University’s (BYU) efforts to advance Alzheimer’s disease genetics research. This collaboration involves analysis and interpretation of next-generation sequencing data from more than 1,000 exomes and genomes to identify new genetic variants associated with the disease.

“Collaboration is the key to discovering novel variants in genomics research, and Tute Genomics is honored to play a role in supporting this important work,” said Dr. Kai Wang, President of Tute Genomics, “This is an example of how our platform significantly enhances the ability for researchers to identify disease genes and variants from thousands of genomes.”

Dr. John “Keoni” Kauwe is leading a group of scientists from the BYU College of Life Sciences that is leveraging Tute Genomics in a large-scale effort to better understand the genetic basis of Alzheimer’s disease. The causes of this brain disease are still not fully understood and traditional treatments have so far proven unsuccessful. Dr. Kauwe’s group is looking to utilize Tute Genomics’ biomarker discovery platform to identify novel targets that may be used for therapeutic interventions.

“We have been extremely impressed with the Tute platform thus far, and we already have a number of research findings we are evaluating. We are excited to utilize Tute’s technology to support our novel approaches to finding genetic variants associated with Alzheimer’s disease using exome and whole genome sequence data,” said Dr. Kauwe.

The Alzheimer’s Genetic Analysis Group is a collaborative effort led by Dr. John Hardy at University College London. Other Principal Investigators in this group include Dr. Kauwe from BYU, Drs. Alison Goate and Carlos Cruchaga at the Washington University School of Medicine, and Dr. Andrew Singleton at the National Institutes of Health. Late last year this group discovered a novel genetic variant that doubles a person’s risk of developing the disease later in life. The study included families that had several members with Alzheimer’s. The scientists sequenced and compared genes of those individuals affected by the disease and those who were not. They were then able to identify variations in a gene that appeared in affected family members.

Another of their recent studies has helped lift the veil on some of the mystery surrounding the causes of Alzheimer’s. The research team analyzed data from more than 25,000 people and reported that a rare genetic mutation in TREM2, a gene with function in the immune and inflammatory response, increases the risk of Alzheimer’s disease.

“Dr. Kauwe and the Alzheimer’s Genetic Analysis Group are making exciting progress towards understanding the genetic underpinnings of Alzheimer’s disease. The first step towards effective treatments and an eventual cure is to fully understand the genetics and neurobiology of the disorder,” said Dr. Reid Robison, co-founder and CEO of Tute Genomics.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More than 4,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Tute Genomics Platform Selected to Provide Clinical Interpretation for NextStepDx PLUS
Genetic testing service designed to detect genetic variants linked to autism spectrum disorders and other disorders of childhood development.
Saturday, July 12, 2014
Scientific News
New CAR T Cell Therapy Using Double Target Aimed at Solid Tumors
Researchers at Penn University have described how antibody, carbohydrate combination could apply to range of cancer types.
Erasing Unpleasant Memories with a Genetic Switch
Researchers from KU Leuven and the Leibniz Institute for Neurobiology have managed to erase unpleasant memories in mice using a 'genetic switch'.
New Method Detects Telomere Length for Research into Cancer, Aging
UT Southwestern Medical Center cell biologists have identified a new method for determining the length of telomeres, the endcaps of chromosomes, which can influence cancer progression and aging.
Assessing the Effectiveness of Genome-Editing Technologies
Researchers have developed a cost-effective and rapid method for assessing edits generated by CRISPR-Cas9 and other genome-editing technologies.
New Cancer Drug Target Found in Dual-Function Protein
Findings from a study from TSRI have shown that targeting a protein called GlyRS might help to halt cancer growth.
Alzheimer's Genetics Point To New Research Direction
A University of Adelaide analysis of genetic mutations which cause early-onset Alzheimer’s disease suggests a new focus for research into the causes of the disease.
Contagious Cancers Are Spreading in Shellfish
Direct transmission of cancer among some marine animals may be more common than once thought, suggests a new study published in Nature by researchers at Columbia University Medical Center (CUMC).
Contagious Cancers Are Spreading in Shellfish
Direct transmission of cancer among some marine animals may be more common than once thought, suggests a new study published in Nature by researchers at Columbia University Medical Center (CUMC).
Fix for 3-Billion-Year-Old Genetic Error
Researchers at The University of Texas at Austin have developed a fix that allows RNA to accurately proofread for the first time.
Higher Frequency of Huntington's Disease Mutations Discovered
University of Aberdeen study shows that the gene change that causes Huntington's disease is much more common than previously thought.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!